The project team will analyze the market opportunity for a novel NGS library preparation kit for Illumina NGS systems that, in addition to primary sequence, captures long-range information enabling large structural variant detection and haplotype phasing along with 3D chromatin architecture.

The BCBA project team will conduct a survey to evaluate and prioritize cardiovascular, metabolic, and neuro indications for an early stage company’s target discovery platform that leverages the power of comparative biology to develop therapeutics.

The multi-institutional project team will conduct a survey to evaluate and prioritize ocular indications for a venture-backed company’s novel gene editing platform.

Lupa Bio is a start-up company founded to advance evolutionary biology with an aim to disrupt the prescription anti-inflammatory market.  They are an innovative, Indie Bio-funded company with a founding team

The multi-institutional project team will analyze and prioritize oncology targets for drug development by an early stage, venture-backed company with an innovative medicinal chemistry platform

The multi-institutional project team will evaluate the drug discovery landscape to prioritize market entry points for a versatile human stem cell-based technology platform that can be used in preclinical testing

The multi-institutional project team will conduct a survey to evaluate and prioritize oncological indications for an innovative food-based cancer therapy that exploits nutritional disparities in cancer cell metabolism